Toward radiomics for assessment of response to systemic therapies in lung cancer
Toward radiomics for assessment of response to systemic therapies in lung cancer |
|
https://doi.org/10.18632/oncotarget.27847
Shawn Sun,
Florent L. Besson,
Binsheng Zhao,
Lawrence H. Schwartz,
and Laurent Dercle
|
| 4677-4680 |
MicroRNA-4287 is a novel tumor suppressor microRNA controlling epithelial-to mesenchymal transition in prostate cancer
MicroRNA-4287 is a novel tumor suppressor microRNA controlling epithelial-to mesenchymal transition in prostate cancer |
|
https://doi.org/10.18632/oncotarget.27849
Divya Bhagirath,
Thao Ly Yang,
Theresa Akoto,
Nikhil Patel,
Laura Z. Tabatabai,
and Sharanjot Saini
|
| 4681-4692 |
NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy
NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy |
|
https://doi.org/10.18632/oncotarget.27845
Yvonne Cornejo,
Min Li,
Thanh H. Dellinger,
Rachael Mooney,
Masmudur M. Rahman,
Grant McFadden,
Karen S. Aboody,
and Mohamed Hammad
|
| 4693-4698 |
miR-708-5p enhances erlotinib/paclitaxel efficacy and overcomes chemoresistance in lung cancer cells
miR-708-5p enhances erlotinib/paclitaxel efficacy and overcomes chemoresistance in lung cancer cells |
|
https://doi.org/10.18632/oncotarget.27840
Nicholas J. Monteleone,
and Carol S. Lutz
|
| 4699-4721 |
PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer
PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer |
|
https://doi.org/10.18632/oncotarget.27846
Michael Rees,
Chris Smith,
Peter Barrett-Lee,
and Steve Hiscox
|
| 4722-4734 |
Differential gene expression in cisplatin-resistant and -sensitive testicular germ cell tumor cell lines
Differential gene expression in cisplatin-resistant and -sensitive testicular germ cell tumor cell lines |
|
https://doi.org/10.18632/oncotarget.27844
Jan Roška,
Lenka Wachsmannová,
Lenka Hurbanová,
Zuzana Šestáková,
Thomas Mueller,
Dana Jurkovičová,
and Miroslav Chovanec
|
| 4735-4753 |
Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme
Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme |
|
https://doi.org/10.18632/oncotarget.27842
Vishnu S. Mishra,
Naveen Kumar,
Masoom Raza,
and Seema Sehrawat
|
| 4754-4769 |
Alphastatin-C a new inhibitor of endothelial cell activation is a pro-arteriogenic agent in vivo and retards B16-F10 melanoma growth in a preclinical model
Alphastatin-C a new inhibitor of endothelial cell activation is a pro-arteriogenic agent in vivo and retards B16-F10 melanoma growth in a preclinical model |
|
https://doi.org/10.18632/oncotarget.27839
Adilson Kleber Ferreira,
Brunella Cristofaro,
Milene Cristina Menezes,
Ana Karina de Oliveira,
Alexandre Keiji Tashima,
Robson Lopes de Melo,
Cristiane Castilho Fernandes Silva,
Miryam Guillermina Palomino Rodriguez,
Daniela Cajado de Oliveira Souza Carvalho,
Ricardo Alexandre de Azevedo,
Paulo Luiz de Sá Junior,
Lisley Inata Mambelli,
Fernanda Vieira Portaro,
Luc Pardanaud,
Anne Eichmann,
Osvaldo Augusto Sant’Anna,
and Mxarcella Faria
|
| 4770-4787 |
